Sugi Predict

Sugi Predict / Compounds / SCHEMBL693477

SCHEMBL693477

SCHEMBL693477

Cn1ccnc1CCC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 1/20 0.47
▸ FNTB P49356 1/20 0.47
▸ FDPS P14324 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.44
▸ ESR1 P03372 1/20 0.41
▸ CNR2 P34972 1/20 0.40
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ EGLN3 Q9H6Z9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28813244 0.98 FNTA (0.46) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL26488892 0.89 FNTA (0.48) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL5541391 0.88 FNTA (0.47) FNTAFNTBFDPSKMT2AMEN1
Hydrochloric Acid SCHEMBL28457259 0.88 FNTA (0.47) FNTAFNTBFDPSKMT2AMEN1
Bromide SCHEMBL28463232 0.88 FNTA (0.47) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL6979111 0.86 FNTA (0.44) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL5533480 0.86 TBXAS1 (0.46) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL5535511 0.86 TBXAS1 (0.46) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL5538582 0.86 TBXAS1 (0.46) FNTAFNTBFDPSKMT2AMEN1
SCHEMBL5535723 0.86 TBXAS1 (0.46) FNTAFNTBFDPSKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108525655-A A kind of preparation method of the novel composite catalyst that hydroxyl is oxidized to carbonyl and application 扬州工业职业技术学院 2018-09-14 — — CN claimed
CN-108525656-A A kind of micron flower pattern composite catalyst and its application by oxidation of phenol for 1,4-benzoquinone 扬州工业职业技术学院 2018-09-14 — — CN claimed
EP-4029868-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2026-05-20 — — EP disclosed
CN-118804981-A Method for processing biomass material 普罗奥尼克股份有限公司 2024-10-18 — — CN disclosed
CN-117903059-A Preparation method of ligand compound 浙江瑞博制药有限公司 2024-04-19 — — CN disclosed
CN-117304130-A MCL-1 inhibitors 吉利德科学公司 2023-12-29 — — CN disclosed
US-20230312490-A1 MCL-1 INHIBITORS GILEAD SCIENCES, INC. 2023-10-05 — — US disclosed
CN-112118845-B MCL-1 inhibitors 吉利德科学公司 2023-06-13 — — CN disclosed
US-11643400-B2 MCL-1 inhibitors GILEAD SCIENCES, INC. (US) 2023-05-09 — — US disclosed
US-20230014907-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED 2023-01-19 — — US disclosed
US-20220340535-A1 MCL-1 INHIBITORS GILEAD SCIENCES, INC. 2022-10-27 — — US disclosed
US-20080260749-A1 Novel Tetrahydropyridothiophenes NYCOMED GMBH (DE) 2008-10-23 — — US disclosed
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 — — EP disclosed
EP-1790636-A1 PIPERIDINE DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-05-30 — — EP disclosed
EP-1756112-A1 PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS Boehringer Ingelheim International GmbH (DE) 2007-02-28 — — EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 — — WO disclosed
US-20060142337-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-29 — — US disclosed
US-20050261350-A1 Pyrrolobenzimidazolones and their use as anti-proliferative agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 — — US disclosed
WO-2005111040-A1 PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 — — WO disclosed
EP-1598353-A1 Pyrrolobenzimidazolones and their use as antiproliferative agents Boehringer Ingelheim International GmbH (DE) 2005-11-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312490-A1 MCL-1 INHIBITORS MCL1, BCL2L1, BCL2 FNTA 3422/4885FNTB 1761/4885FDPS 3576/4885
US-20230014907-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME APOL1, APOB, NPC1L1 FNTA 1346/4885FNTB 1288/4885FDPS 1161/4885
US-11643400-B2 MCL-1 inhibitors MCL1, BCL2L1, BCL2 FNTA 3422/4885FNTB 1761/4885FDPS 3576/4885
US-20080260749-A1 Novel Tetrahydropyridothiophenes BAX, BCL2, CCAR2 FNTA 1178/4885FNTB 698/4885FDPS 1274/4885
US-20050261350-A1 Pyrrolobenzimidazolones and their use as anti-proliferative agents MKI67, CCNI, CCNA1 FNTA 4174/4885FNTB 3750/4885FDPS 2162/4885
US-20060142337-A1 Piperidine derivative and use thereof AR, AHR, ARNT FNTA 4089/4885FNTB 3964/4885FDPS 4472/4885
US-20220340535-A1 MCL-1 INHIBITORS MCL1, BCL2L1, BCL2 FNTA 3422/4885FNTB 1761/4885FDPS 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.